Fentanyl Market Analysis

  • Report ID: 3762
  • Published Date: Jul 24, 2024
  • Report Format: PDF, PPT

Fentanyl Market Analysis

End-user (Hospital, Oncology Centers, Surgical Centers)

The global fentanyl market is segmented and analyzed for demand and supply by end user into hospital, oncology centers, surgical centers, and others. Out of the four types of end users, the oncology centers segment is estimated to gain the largest market share of about 35% in the year 2036. The growth of the segment can be accredited to the fact that oncology centers specifically offer cancer treatments. An increasing pool of cancer patients is also estimated to boost the growth of the segment. In addition, the growth of the hospital segment can be accredited to the large number of patients requiring treatment for cancer conditions. The hospitals are also growing rapidly in number, which is estimated to positively influence the segmental growth. For instance, by the year 2022 there was noted to be approximately 6,100 hospitals in the United States. Hospitals provide a wide range of medical care. Physicians, called hospital doctors, typically specialize in internal medicine, pediatrics, or general practice. They have the knowledge to solve common problems and the resources to solve more complex medical problems. Hospitals may also offer specialized care, such as neurology, obstetrics and gynecology, and oncology.

Route of Administration (Sublingual Tablet, Buccal Tablet, Oral Film)

The global fentanyl market is also segmented and analyzed for demand and supply by route of administration into sublingual tablet, buccal tablet, oral film, and others. Amongst these four segments, the oral film segment is expected to garner a significant share of around 30% in the year 2036. The growth of the segment can be accredited to the fact that fentanyl retains half of its analgesic properties when taken orally, hence the safer effects of fentanyl when taken orally. Across the world, it has been noted that aged people are more prone to cancer and for them oral route of administration is much more easier than other methods. Overall cancer incidence increases steadily with age, from less than 25 cases per 100,000 under 20 years to more than 1000 cases per 100,000 people for aged 60 years and over. Hence, this is estimated to add to the segmental growth notably.

Our in-depth analysis of the global market includes the following segments:

            By End User

  • Hospital
  • Oncology Centers
  • Surgical Centers
  • Others

 

   

      By Route of Administration

  • Sublingual Tablet
  • Buccal Tablet
  • Oral Film
  • Others 
Get more information on this report: Request Free Sample PDF

Browse Key Market Insights with Data Illustration:


Author Credits:  Radhika Pawar


  • Report ID: 3762
  • Published Date: Jul 24, 2024
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

In the year 2024, the industry size of fentanyl is evaluated at USD 16.85 Billion.

The fentanyl market size was valued at USD 15.95 Billion in 2023 and is anticipated to exceed USD 35.28 Billion by the end of 2036, expanding at over 6.3% CAGR during the forecast period i.e., between 2024-2036. Growing incidences of cancer and the growing oncology spending are the major factors driving the market growth.

North America is poised to dominate majority industry share of about 35% by 2036, attributed to growing population and research activity, and health insurance covering various cancer diagnoses.

Thermo Fisher Scientific Inc., Boehringer Ingelheim GmbH, Bayer AG, Novartis AG, Sanofi-aventis Groupe, Abbott Laboratories, Merck & Co., Inc., Validus Pharmaceuticals LLC, Teva Pharmaceutical Industries Ltd., Siemens Healthcare GmbH
Inquiry Before Buying Request Free Sample
logo
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying